| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4660 | Scr1693 | Novel dual acetylcholinesterase inhibitor (AChEI) and a calcium channel blocker (CCB) |
|
| DCC4661 | Scr-4026 | Novel inhibitor of nNOS-PSD-95 interaction, exhibiting neuroprotective activities in NMDA-induced or Oxygen and glucose deprivation (OGD)-induced neuronal damage in primary cortical neurons cultures, and ameliorating focal cerebral ischemic damage in rats |
|
| DCC4662 | Scriptene | NRTI-drug pair of zidovudine (AZT)-didanosine (ddI), being highly cytotoxic and mutagenic |
|
| DCC4663 | S-cw3554 | Novel irriversible selective PDI inhibitor, selectively labeling protein disulfide isomerase and inhibiting its enzymatic activity, showing unique cytotoxicity in cells derived from multiple myeloma |
|
| DCC4664 | Sd2590 Hydrochloride | Potent inhibitor of MMP-2, -3, -9, -8, -13, and -14 |
|
| DCC4665 | Sdz 205-557 Hydrochloride | Selective, surmountable antagonist for 5-HT4 receptors |
|
| DCC4666 | Sdz 90-215 | Novel inhibitor of the Golgi complex (Vrg4); Antifungal |
|
| DCC4667 | Sdz Mrl 953 | Novel immunostimulatory monosaccharidic lipid A analog, down-regulating TNF-alpha and IL-6 production and priming secretion of G-CSF and IL-1 beta |
|
| DCC4668 | Sdz Ser 082 Fumarate | Selective 5-HT2B/2C receptor antagonist |
|
| DCC4669 | sdz-285604 | Novel inhibitor of sterol 14a-demethylases (CYP51) |
|
| DCC4670 | Sdz-lap-977 | Potent antiproliferative agent, binding to the “colchicine binding site” on tubulin and inhibiting tubulin polymerization in vitro |
|
| DCC4671 | sdz-nkt343 | Highly selective human tachykinin NK1 receptor antagonist |
|
| DCC4672 | Secologanate | Natural plant growth inhibitor |
|
| DCC4673 | Seco-rapamycin Ethyl Ester | Novel open-ring metabolite of rapamycin derivative |
|
| DCC4674 | Securinine Mononitrate | Antagonist of gamma-aminobutyric acid A (GABA A ) receptor and cholinergic agent |
|
| DCC4675 | Seh/ache Inhibitor 12c | Novel Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease |
|
| DCC4676 | Seh-in-12 | Novel potent inhibitor of the enzyme soluble epoxide hydrolase (sEH) |
|
| DCC4677 | Sempai | Novel AkaLumine analog, acting asa NIR emission luciferin with the enhanced solubility in water |
|
| DCC4678 | Sen205a | Novel S100B inhibitor |
|
| DCC4679 | Sen461 | Novel Wnt inhibitor/Axin stabilizer |
|
| DCC4680 | Sen-826 | Novel potent antagonist of the Hedgehog pathway |
|
| DCC4681 | Senp1-in-8e | Sentrin-specific protease 1 (SENP1) inhibitor |
|
| DCC4682 | Se-nsaid-8 | Novel selenium-nonsteroidal anti-inflammatory drug (Se-NSAID), inhibiting colorectal cancer (CRC) growth via the inhibition of the cell cycle in G1 and G2/M phases and reduces the cell cycle markers like cyclin E1 and B1 in a dose dependent manner |
|
| DCC4683 | Sephin1 Hydrochloride | Selective inhibitor of the phosphatase regulatory subunit PPP1R15A (R15A) that prolong the benefit of eIF2α phosphorylation, thereby protecting cells from proteostatic defects |
|
| DCC4684 | Ser@tpp@cur | Novel mitochondrial KIM-1 receptor modulator to be specifically internalized by renal tubular epithelial cells via KIM-1 receptor-mediated endocytosis and then actively distributed in mitochondria under the effect of TPP, effectively ameliorating injured |
|
| DCC4685 | Sert Inhibitor 69419 | Novel serotonin reuptake inhibitor |
|
| DCC4686 | Sertaconazole | Cytochrome P450 14α-demethylase inhibitor, also acting as a BuChE-IDO1 inhibitor |
|
| DCC4687 | Setastine | Highly selective H1 receptor antagonist |
|
| DCC4688 | Sethrrs Inhibitor 36j | The first-in-class triple-site aaRS inhibitor, targeting Salmonella enterica threonyl-tRNA synthetase (SeThrRS) with IC 50 = 19 nM and K d = 35.4 nM |
|
| DCC4689 | Setin-1 | The most potent inhibitor of Set7, inhibiting the KMTase G9a |
|
